Salvage surgery for squamous cell carcinoma of the head and neck in the era of immunotherapy: Is it time to clarify our guidelines?

Cancer. 2018 Nov 1;124(21):4163-4164. doi: 10.1002/cncr.31717. Epub 2018 Oct 5.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cetuximab / administration & dosage
  • Combined Modality Therapy
  • Fluorouracil / administration & dosage
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / surgery*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Immunotherapy* / methods
  • Immunotherapy* / standards
  • Immunotherapy* / trends
  • Medical Oncology / standards*
  • Medical Oncology / trends
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / therapy
  • Oral Surgical Procedures / methods
  • Oral Surgical Procedures / standards
  • Platinum Compounds / administration & dosage
  • Practice Guidelines as Topic* / standards
  • Salvage Therapy / methods*
  • Salvage Therapy / standards
  • Squamous Cell Carcinoma of Head and Neck / mortality
  • Squamous Cell Carcinoma of Head and Neck / pathology
  • Squamous Cell Carcinoma of Head and Neck / surgery*
  • Squamous Cell Carcinoma of Head and Neck / therapy
  • Standard of Care
  • Surgical Procedures, Operative / methods
  • Surgical Procedures, Operative / standards

Substances

  • Platinum Compounds
  • Cetuximab
  • Fluorouracil